Zurcher Kantonalbank (Zurich Cantonalbank) Biocryst Pharmaceuticals Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$39 Billion
Q2 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 58,095 shares of BCRX stock, worth $415,379. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,095

Previous 58,216 0.21%

Holding current value

$415,379

Previous $436,000 19.27%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$6.41 - $11.19 $775 - $1,353	-121 Reduced 0.21%	58,095 $520,000
Q1 2025 May 07, 2025	SELL	$7.06 - $9.39 $211 - $281	-30 Reduced 0.05%	58,216 $436,000
Q4 2024 Feb 07, 2025	BUY	$7.03 - $8.43 $50,855 - $60,982	7,234 Added 14.18%	58,246 $438,000
Q3 2024 Nov 07, 2024	BUY	$6.41 - $8.69 $23,415 - $31,744	3,653 Added 7.71%	51,012 $387,000
Q4 2023 Jan 30, 2024	BUY	$4.98 - $6.77 $50,228 - $68,282	10,086 Added 27.06%	47,359 $283,000
Q3 2023 Oct 25, 2023	SELL	$6.71 - $7.92 $13 - $15	-2 Reduced 0.01%	37,273 $263,000
Q2 2023 Aug 07, 2023	BUY	$6.96 - $8.81 $62,257 - $78,805	8,945 Added 31.57%	37,275 $262,000
Q1 2023 May 08, 2023	BUY	$7.94 - $11.84 $13,204 - $19,689	1,663 Added 6.24%	28,330 $236,000
Q4 2022 Feb 01, 2023	BUY	$10.5 - $14.2 $14,122 - $19,099	1,345 Added 5.31%	26,667 $306,000
Q1 2022 Apr 21, 2022	SELL	$11.56 - $19.76 $60,401 - $103,246	-5,225 Reduced 17.1%	25,322 $412,000
Q4 2021 Feb 01, 2022	BUY	$11.18 - $15.46 $41,533 - $57,433	3,715 Added 13.85%	30,547 $423,000
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $937 - $1,164	66 Added 0.25%	26,832 $386,000
Q2 2021 Jul 30, 2021	BUY	$9.5 - $17.24 $22,923 - $41,600	2,413 Added 9.91%	26,766 $423,000
Q1 2021 May 03, 2021	BUY	$7.37 - $13.61 $4,156 - $7,676	564 Added 2.37%	24,353 $248,000
Q2 2020 Jul 28, 2020	BUY	$1.9 - $5.61 $11,835 - $34,944	6,229 Added 35.47%	23,789 $113,000
Q1 2020 May 06, 2020	BUY	$1.6 - $4.11 $18,227 - $46,821	11,392 Added 184.7%	17,560 $35,000
Q4 2017 Jan 31, 2018	BUY	$4.16 - $5.33 $18,166 - $23,276	4,367 Added 242.48%	6,168 $30,000
Q3 2017 Nov 08, 2017	BUY	$4.1 - $5.97 $7,384 - $10,751	1,801	1,801 $9,000

Others Institutions Holding BCRX

# of Institutions

316

Shares Held

202M

Call Options Held

930K

Put Options Held

553K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.33B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Biocryst Pharmaceuticals Inc Transaction History